1. A point-of care urine test to predict preeclampsia development in Asian women with suspected preeclampsia.
- Author
-
Wong, Sani T.K., Sahota, Daljit S., Wong, Natalie K.L., Wah, Isabella Y.M., Wang, Xueqin, Lau, S.L., Chiu, C.P.H., IP, Patricia N.P., and Poon, Liona C.
- Abstract
• The median intervals between the initial test and the diagnosis of PE and delivery are significantly shorter for women with a positive urine CRDT than a negative urine CRDT. • Urine Congo Red Dot Test (CRDT) alone has low sensitivity in the short-term prediction of preeclampsia in patients presented with signs/ symptoms of suspected preeclampsia. To evaluate the diagnostic performance and clinical utility of the urine Congo red dot test (CRDT) in predicting preeclampsia (PE) within 7 days, 14 days and 28 days of assessment. A prospective single center double blind non-intervention study conducted from January 2020 to March 2022. Urine congophilia has been proposed as a point-of-care test for the prediction and rapid identification of PE. In our study, urine CRDT and pregnancy outcomes were assessed in women presenting with clinical features of suspected PE after 20 weeks of gestation. Among the 216 women analyzed, 78 (36.1 %) women developed PE, in which only 7 (9.0 %) of them had a positive urine CRDT test. The median (IQR) interval between the initial test and the diagnosis of PE was significantly shorter for women with a positive urine CRDT compared with women with a negative urine CRDT (1 day (0–5 days) vs 8 days (1–19 days), P = 0.027). The negative predictive value of a negative urine CRDT test for PE within 7 days, 14 days and 28 days of assessment were 83.73 % (95 %CI 81.75 %- 85.54 %), 78.92 % (95 % confidence interval [CI] 77.07 %- 80.71 %) and 71.77 % (95 %CI 70.06 %- 73.42 %) respectively. The sensitivity of the urine CRDT in ruling in PE within 7 days, 14 days and 28 days of assessment were 17.07 % (95 %CI 7.15 %- 32.06 %), 13.73 % (95 %CI 5.70 %- 26.26 %) and 10.61 % (95 %CI 4.37 %- 20.64 %), respectively. Urine CRDT alone has high specificity yet low sensitivity in the short-term prediction of PE in women with suspected PE. Further studies are required to evaluate its clinical utility. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF